novartis ceo: demand has surged for therapeutics
Published 3 years ago • 1.6K plays • Length 3:47Download video MP4
Download video MP3
Similar videos
-
4:43
novartis ceo: our leukemia drug scemblix is a potential $3 billion plus medicine
-
5:53
novartis expects 'strong momentum' going into second half, says ceo vasant narasimhan
-
4:22
novartis ceo on new cancer therapy programs
-
3:29
novartis generated $40 billion in innovative medicine sales, says ceo
-
4:23
charles schwab's sonders: here's how investors should navigate this 'unique market'
-
7:02
verizon ceo hans vestberg on $20b frontier deal: enhances and accelerates our broadband efforts
-
2:39
nvidia denies receiving doj subpoena in antitrust probe
-
3:43
novartis ceo vas narasimhan on the latest research on a breast cancer drug
-
14:53
took a hard decision to focus on 4 therapeutic areas: novartis ceo | exclusive | cnbc tv18
-
2:05
ceo of swiss drugmaker novartis outlines some major industry trends for 2024
-
4:17
novartis ceo: we expect our six key drugs to grow ahead of analyst expectations
-
1:51
committed to growing over 4% through 2026, says novartis ceo
-
6:12
novartis ceo: expect continued growth in 2023
-
7:51
watch cnbc's full interview with novartis ceo vas narasimhan
-
4:37
novartis positioning is now best-suited for long-term gains and returns after spin-off, says ceo
-
0:57
novartis global ceo vas narasimhan: ai's impact on pharma and clinical trial realities | n18s
-
4:11
novartis ceo on esg: pandemic has been a reset for pharma's reputation
-
8:47
novartis ceo: prescriptions in the pipeline | mad money | cnbc
-
3:01
novartis ceo vas narasimhan: strategic approach to weight-loss drug development | n18v | cnbc tv18
-
7:41
novartis ceo on company's approach to covid-19 treatment
-
0:35
novartis ceo on the company's overall m&a strategy #shorts
-
3:42
novartis ceo vasant narasimhan on building trust with society